ATE253913T1 - Anästhetikum - Google Patents

Anästhetikum

Info

Publication number
ATE253913T1
ATE253913T1 AT98954639T AT98954639T ATE253913T1 AT E253913 T1 ATE253913 T1 AT E253913T1 AT 98954639 T AT98954639 T AT 98954639T AT 98954639 T AT98954639 T AT 98954639T AT E253913 T1 ATE253913 T1 AT E253913T1
Authority
AT
Austria
Prior art keywords
saccharide
amount
additional non
anesthetic agent
anesthetic
Prior art date
Application number
AT98954639T
Other languages
English (en)
Inventor
Stephen Brown
Road Milton
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of ATE253913T1 publication Critical patent/ATE253913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT98954639T 1997-11-19 1998-11-19 Anästhetikum ATE253913T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation
PCT/GB1998/003479 WO1999025349A1 (en) 1997-11-19 1998-11-19 Anaesthetic formulation

Publications (1)

Publication Number Publication Date
ATE253913T1 true ATE253913T1 (de) 2003-11-15

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954639T ATE253913T1 (de) 1997-11-19 1998-11-19 Anästhetikum

Country Status (17)

Country Link
US (1) US5932597A (de)
EP (1) EP1032390B1 (de)
JP (1) JP2001522888A (de)
KR (1) KR100695588B1 (de)
CN (1) CN1131033C (de)
AT (1) ATE253913T1 (de)
AU (1) AU740914B2 (de)
BR (1) BR9814883A (de)
CA (1) CA2308495C (de)
DE (1) DE69819770T2 (de)
DK (1) DK1032390T3 (de)
ES (1) ES2209217T3 (de)
HU (1) HU228143B1 (de)
IL (1) IL135922A0 (de)
NO (1) NO328684B1 (de)
PT (1) PT1032390E (de)
WO (1) WO1999025349A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP1575569B1 (de) 2002-12-13 2010-09-29 Durect Corporation Orale darreichungsform mit flüssigen hochviskosen trägersystemen
RS52198B (sr) 2004-09-17 2012-10-31 Durect Corporation Rastvor lokalnog anestetika koji sadrži saib sa održivim delovanjem
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
ES2388355T3 (es) 2006-11-03 2012-10-11 Durect Corporation Sistemas de suministro transdémico que comprenden bupivacaína
EP2219622A1 (de) * 2007-12-06 2010-08-25 Durect Corporation Verfahren zur behandlung von schmerzen, arthritischen zuständen oder entzündung im zusammenhang mit einer chronischen erkrankung
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
EP2882745A2 (de) * 2012-05-10 2015-06-17 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung lokaler schmerzen
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
WO2017009862A1 (en) * 2015-07-13 2017-01-19 Neon Laboratories Limited Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
MY205229A (en) 2016-07-06 2024-10-08 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
WO2025175174A1 (en) * 2024-02-14 2025-08-21 The Children's Medical Center Corporation 2'-6'-pipecoloxylidide as a sensory-selective anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
HK1006420A1 (en) * 1993-10-13 1999-02-26 Chiroscience Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use

Also Published As

Publication number Publication date
CN1279607A (zh) 2001-01-10
WO1999025349A1 (en) 1999-05-27
EP1032390A1 (de) 2000-09-06
DE69819770T2 (de) 2004-09-23
DK1032390T3 (da) 2004-03-15
KR100695588B1 (ko) 2007-03-14
BR9814883A (pt) 2000-10-03
HUP0004665A2 (hu) 2001-04-28
NO20002545L (no) 2000-05-18
JP2001522888A (ja) 2001-11-20
CA2308495A1 (en) 1999-05-27
NO328684B1 (no) 2010-04-26
HK1026848A1 (en) 2000-12-29
IL135922A0 (en) 2001-05-20
CN1131033C (zh) 2003-12-17
NO20002545D0 (no) 2000-05-18
PT1032390E (pt) 2004-04-30
US5932597A (en) 1999-08-03
HUP0004665A3 (en) 2004-05-28
AU740914B2 (en) 2001-11-15
AU1168499A (en) 1999-06-07
KR20010032241A (ko) 2001-04-16
ES2209217T3 (es) 2004-06-16
CA2308495C (en) 2009-01-06
HU228143B1 (en) 2012-12-28
EP1032390B1 (de) 2003-11-12
DE69819770D1 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
DE69819770D1 (de) Anästhetikum
BR0207420A (pt) Processo e composições para desinfecção de superfìcies duras
AU2003298179A1 (en) Lens care composition and method
ATE181465T1 (de) Rahmengestell aus rahmenschenkeln und tiefenstreben
ES2129412T3 (es) Composiciones de detergentes.
DK1361882T3 (da) 4-fluor-N-indan-2-ylbenzamid og dets anvendelse som farmaceutisk middel
EP1295607A4 (de) Antitumoreffekt-verstärker
AR002932A1 (es) Solucion acuosa de interferon
DE60221234D1 (de) Verwendung von füllstoffe als sättigungsmittel
ATE328599T1 (de) Antitumorale mittel
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
ATE359823T1 (de) Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
JP2001522888A5 (de)
HUP0203773A2 (hu) Epinastintartalmú oldatok
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
RU2004102395A (ru) Жидкая композиция, включающая сложный эфир полиоксиэтиленсорбита и жирной кислоты
BR0209206A (pt) Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
EA200200502A1 (ru) Способ введения ингибитора фосфодиэстеразы 4
ATE238803T1 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
ES2137352T3 (es) Composiciones oftalmicas que incluyen emedastina y su utilizacion para tratar conjuntivitis alergicas.
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
DE3875349D1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
DE69320352D1 (de) Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1032390

Country of ref document: EP